Impacts of rebate regulations influenced on expansion of small and medium-sized pharmaceutical companies’ market shares

While causing trouble of businesses for large pharmaceutical companies, restriction on pharmaceutical product rebates has expanded market shares of small and medium-sized pharmaceutical companies.

According to the Shinhan Investment Corp’s analysis result of the UBIST data, expenses of outpatient prescriptions were KRW 761.8 million, which makes a 0.6% decrease rate compared to the same month ...